Table 2 Study participants and RNA sequencing read pairs in millions before, and after pre-mapping quality control
From: Comparing reference-based RNA-Seq mapping methods for non-human primate data
Participant number | Bacterial dose (CFU) | 0 Hours | 6 Hours | 24 Hours | 48 Hours | 168 Hours |
|---|---|---|---|---|---|---|
1 | 0 | 37.0, 36.2 | 44.3, 42.9 | 33.8, 32.9 | 35.5, 34.8 | 32.6, 32.0 |
2 | 0 | 34.0, 33.4 | 31.8, 31.1 | 34.6, 34.0 | 34.0, 32.9 | 35.8,35.2 |
3 | 0 | 31.3, 30.6 | 37.2, 36.5 | 31.1, 30.5 | â—¯ | 36.8, 36.1 |
4 | 106 | 37.8, 37.0 | 31.5, 31.0 | 36.5, 35.8 | 31.1, 30.6 | 35.8, 34.9 |
5* | 107 | 31.2, 30.5 | 35.4, 34.6 | 37.8, 36.9 | 34.0, 33.4 | 35.8, 35.1 |
6* | 108 | 36.3, 35.5 | 32.6, 31.7 | 36.1, 35.3 | 34.5, 33.8 | 34.7, 34.0 |
7* | 108 | 38.0, 37.2 | 32.4, 31.5 | â—¯ | 31.0, 30.4 | 37.6, 36.9 |
8 | 108 | 35.9, 35.2 | 35.3, 34.5 | â—¯ | 31.9, 31.3 | 32.7, 32.0 |
9* | 109 | 36.2, 35.5 | 32.6, 32.0 | 36.6, 35.8 | 33.6, 32.9 | 34.8, 34.1 |
10* | 109 | 34.5, 33.8 | 33.3, 32.8 | 37.6, 36.6 | 36.2, 35.5 | 34.3, 33.7 |
11* | 109 | 35.4, 34.7 | 35.5, 34.7 | 31.9, 31.3 | 35.6, 34.5 | 30.1, 29.5 |
12* | 109 | 36.2, 35.4 | 35.4, 34.8 | 34.8, 34.1 | 30.9, 30.3 | 35.2, 34.6 |